Ignite Creation Date:
2024-05-05 @ 5:34 PM
Last Modification Date:
2024-10-26 @ 9:33 AM
Study NCT ID:
NCT00481065
Status:
COMPLETED
Last Update Posted:
2014-02-03
First Post:
2007-05-31
Brief Title:
Immunogenicity Safety and Tolerability of Prepandemic Influenza and Seasonal Influenza Vaccine in Adult Subjects
Sponsor:
Novartis
Organization:
Novartis
Study Overview
Official Title:
A Phase II Randomized Controlled Open Label Single-Center Study to Evaluate the Immunogenicity Safety and Tolerability of an H5N1-vaccine and a Seasonal Influenza Vaccine in Adult Subjects
Status:
COMPLETED
Status Verified Date:
2013-12
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This study evaluates the immunogenicity safety and tolerability of an H5N1 vaccine with a seasonal trivalent influenza vaccine containing the strains recommended by WHO for the 2007 influenza season in the Southern Hemisphere
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None